Posted inMedical Technology
Johnson & Johnson delivers 10-year Impella gains in severe heart attacks
After demonstrating last year that its miniaturized heart pumps could improve survival shortly after a serious heart attack, Johnson &…
Posted inMedical Technology
Medtronic scores insulin pump clearance in Type 2 diabetes, preps launch of Abbott Instinct CGM
Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed…
Posted inMedical Technology
At ESC 2025, new heart valve guidelines call for earlier TAVR as implant makers expand reach
At the annual meeting of the European Society of Cardiology (ESC), being held this weekend in Madrid, new cardiac care…
Posted inMedical Technology
FDA flags issues in review of Telix’s PET diagnostic agent for kidney cancer
The FDA has asked the radiopharmaceutical developer Telix for more information about the production of its novel PET imaging agent…
Posted inMedical Technology
3D-printed orthopedic implant maker restor3d raises $104M
The personalized orthopedic implant maker restor3d has raised a total of $104 million to boost its commercial plans across shoulder,…
Posted inMedical Technology
Philips rolls out major AI upgrades for cardiac ultrasound platforms
Philips has begun rolling out a major update to its cardiovascular ultrasound systems, incorporating a host of imaging quality upgrades…
Posted inMedical Technology
ProVerum raises $80M for stent aimed at enlarged prostates
ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stentlike implant to…
Posted inMedical Technology
Abbott’s absorbable, below-the-knee stent nets European approval in peripheral artery disease
Abbott has collected a green light in Europe for its dissolving, drug-laden stent in peripheral artery disease, following its approval…
Posted inMedical Technology
Terumo inks $1.5B deal for liver transplant tech developer OrganOx
After raising more than $142 million in venture capital earlier this year to support its liver transplant technology, OrganOx is…
Posted inMedical Technology
Tempus claims AI pathology developer Paige in $81M deal
Tempus AI has acquired the digital pathology developer Paige, including its FDA-cleared, artificial intelligence-powered programs for spotting the signs of…